bioAffinity Technologies, Inc. (BIAFW) stock
BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value
$0.24+0.00 (0.00%)
Close on Oct 30, 2026Market cap $23.58MP/E –Yield –
bioAffinity Technologies price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
bioAffinity Technologies's price to book ratio was 6.3× on Oct 19, 2026, against 60.3× a year earlier. Over the last 4 years it ranged from 6.3× to 104.4×, with a median of 27.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 6.3× | −0.6 |
| 2025 | Dec 31, 2025 | 6.9× | −51.8 |
| 2024 | Dec 31, 2024 | 58.7× | +29.6 |
| 2023 | Dec 29, 2023 | 29.1× | +13.1 |
| 2022 | Dec 30, 2022 | 15.9× | – |